Tang Capital Management LLC Corvus Pharmaceuticals, Inc. Transaction History

Tang Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.87 - $2.03 $174,000 - $405,999	200,000 Added 6.45%	3,301,709 $3.27 Million
Q4 2021 Feb 14, 2022	SELL	$2.34 - $5.31 $1.52 Million - $3.44 Million	-647,670 Reduced 17.27%	3,101,709 $7.48 Million
Q3 2021 Nov 15, 2021	BUY	$1.89 - $8.53 $7.09 Million - $32 Million	3,749,379 New	3,749,379 $18.1 Million

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $381M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.